Bis-choline tetrathiomolybdate: Completed Phase II enrollment

Wilson completed enrollment of 28 adult patients in the open-label, international Phase II WTX101-201 trial evaluating once-daily oral Decuprate. The

Read the full 209 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE